These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 26905802

  • 1. Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.
    Gómara MJ, Sánchez-Merino V, Paús A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I.
    Biochim Biophys Acta; 2016 Jun; 1860(6):1139-48. PubMed ID: 26905802
    [Abstract] [Full Text] [Related]

  • 2. A cyclic GB virus C derived peptide with anti-HIV-1 activity targets the fusion peptide of HIV-1.
    Galatola R, Vasconcelos A, Pérez Y, Cruz A, Pujol M, Alsina MA, Gómara MJ, Haro I.
    Eur J Med Chem; 2014 Oct 30; 86():589-604. PubMed ID: 25218908
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. GB virus type C interactions with HIV: the role of envelope glycoproteins.
    Mohr EL, Stapleton JT.
    J Viral Hepat; 2009 Nov 30; 16(11):757-68. PubMed ID: 19758271
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.
    Herrera E, Gomara MJ, Mazzini S, Ragg E, Haro I.
    J Phys Chem B; 2009 May 21; 113(20):7383-91. PubMed ID: 19402654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.
    Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.
    J Virol; 2011 Jul 21; 85(14):7037-47. PubMed ID: 21543477
    [Abstract] [Full Text] [Related]

  • 10. HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected].
    Eissmann K, Mueller S, Sticht H, Jung S, Zou P, Jiang S, Gross A, Eichler J, Fleckenstein B, Reil H.
    PLoS One; 2013 Jul 21; 8(1):e54452. PubMed ID: 23349893
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.
    McLinden JH, Stapleton JT, Klinzman D, Murthy KK, Chang Q, Kaufman TM, Bhattarai N, Xiang J.
    J Gen Virol; 2013 Apr 21; 94(Pt 4):774-782. PubMed ID: 23288422
    [Abstract] [Full Text] [Related]

  • 14. Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat.
    Izumi K, Nakamura S, Nakano H, Shimura K, Sakagami Y, Oishi S, Uchiyama S, Ohkubo T, Kobayashi Y, Fujii N, Matsuoka M, Kodama EN.
    Antiviral Res; 2010 Aug 21; 87(2):179-86. PubMed ID: 20438763
    [Abstract] [Full Text] [Related]

  • 15. Surface behavior of peptides from E1 GBV-C protein: Interaction with anionic model membranes and importance in HIV-1 FP inhibition.
    Galatola R, Cruz A, Gómara MJ, Prat J, Alsina MA, Haro I, Pujol M.
    Biochim Biophys Acta; 2015 Feb 21; 1848(2):392-407. PubMed ID: 25450346
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
    Zheng B, Wang K, Lu L, Yu F, Cheng M, Jiang S, Liu K, Cai L.
    AIDS; 2014 Jun 01; 28(9):1251-60. PubMed ID: 24625369
    [Abstract] [Full Text] [Related]

  • 18. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
    Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.
    Cell; 2007 Apr 20; 129(2):263-75. PubMed ID: 17448989
    [Abstract] [Full Text] [Related]

  • 19. Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage.
    Fernández-Vidal M, Rojo N, Herrera E, Gómara MJ, Haro I.
    Biophys Chem; 2008 Jan 20; 132(1):55-63. PubMed ID: 17988786
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.